
Injectable, Structural Regenerative Implant for Cartilage Care
Protect • Repair • Regenerate
← Back HomeBrowse every article and treatment insight.

ChondroFiller is a collagen scaffold injected into ankle cartilage defects to create a biological matrix that triggers the body's own repair cells to migrate and remodel the tissue. The procedure is single-stage and outpatient, typically lasting 30 to 45 minutes.

An ACL rupture instantly compresses cartilage and bone where the tibia meets the femur as the tibia rotates and shifts forward forcefully. This structural damage occurs independently of the mechanical instability that follows; progressive cartilage degradation subsequently unfolds over months as the joint loses restraint.

For patients with Grade III or IV hip osteoarthritis, ChondroFiller injection—an outpatient ultrasound-guided treatment using a collagen scaffold—offers an alternative to replacement by preserving the native joint and triggering the body's own cartilage regeneration.

Lesion size determines treatment success in talar osteochondral defects: bone marrow stimulation succeeds in nearly all cases below 15 mm average diameter, but only 3% of lesions at or above that threshold.

For focal osteochondral lesions of the talus larger than 15 mm, bone marrow stimulation alone succeeds only 3% of the time; ChondroFiller, an injectable collagen scaffold placed under ultrasound guidance, offers a non-surgical pathway using the patient's own repair cells—no general anaesthetic or surgical incision.

Anterior knee pain does not reliably indicate cartilage damage; symptoms correlate only loosely with structural grade, requiring imaging and functional testing for accurate diagnosis.

Cartilage damage won’t reverse on its own—yet with the right plan it can be protected, repaired, and regenerated.
At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.
(Consultation fee credited towards treatment if you proceed.)